The store will not work correctly when cookies are disabled.
Benzo[b]thiophen-3-ylmethyl-methyl-(3-phenyl-allyl)-amine
ID: ALA2093009
PubChem CID: 70687141
Max Phase: Preclinical
Molecular Formula: C19H19NO
Molecular Weight: 277.37
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C/C=C/c1ccccc1)Cc1coc2ccccc12
Standard InChI: InChI=1S/C19H19NO/c1-20(13-7-10-16-8-3-2-4-9-16)14-17-15-21-19-12-6-5-11-18(17)19/h2-12,15H,13-14H2,1H3/b10-7+
Standard InChI Key: IOIQACBBCWWAAH-JXMROGBWSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
1.8831 -6.7765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1086 -7.5699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5449 -8.1711 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.5052 -7.1690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7390 -7.9665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2797 -6.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4259 -5.6409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1398 -6.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9979 -5.6409 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8621 -5.6409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7119 -6.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2881 -6.9769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1754 -8.5594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9979 -4.8142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8621 -4.8142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5761 -6.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8601 -7.5699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6221 -8.3673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2943 -5.6409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5761 -4.4008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2943 -4.8142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 1 1 0
5 4 2 0
6 1 1 0
7 11 1 0
8 7 2 0
9 6 1 0
10 8 1 0
11 9 1 0
12 4 1 0
13 5 1 0
14 9 1 0
15 10 2 0
16 10 1 0
17 12 2 0
18 17 1 0
19 16 2 0
20 15 1 0
21 19 1 0
3 5 1 0
18 13 2 0
20 21 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 277.37 | Molecular Weight (Monoisotopic): 277.1467 | AlogP: 4.58 | #Rotatable Bonds: 5 |
Polar Surface Area: 16.38 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.33 | CX LogP: 4.41 | CX LogD: 3.43 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.68 | Np Likeness Score: -0.33 |
References
1. Stütz A, Georgopoulos A, Granitzer W, Petranyi G, Berney D.. (1986) Synthesis and structure-activity relationships of naftifine-related allylamine antimycotics., 29 (1): [PMID:3510297] [10.1021/jm00151a019] |